As ACLY, ACC, and FASN are frequently upregulated in tumor cells and their inhibition reduces tumor growth, it is widely recognized that the increased capacity for producing lipids de novo is a crucial determinant for the tumor progression. The gene discussed is ACLY; the disease is neoplasm.